drugset / Trial / NCT03425396

Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis

NCT03425396

Phase 2 Completed 225 enrolled Paratek Pharmaceuticals Inc
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of oral omadacycline as compared to oral nitrofurantoin in the treatment of female adults with cystitis.

Timeline

Start
2018-01-04
Primary completion
2019-05-15
Completion
2019-06-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitrofurantoin Unknown 100 mg Oral
Subject Omadacycline Small molecule 300 mg Oral
Subject Omadacycline Small molecule 450 mg Oral